Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Further information Invitation to participate
Process STA Standard
ID number 6411

Provisional Schedule

Expected publication 12 February 2025

Project Team

Project lead Kate Moore

Email enquiries

External Assessment Group Centre for Reviews and Dissemination and Centre for Health Economics, University of York


Companies sponsors AstraZeneca (dapagliflozin)
Others Department of Health and Social Care
  NHS England
Patient carer groups Kidney Care UK
  Kidney Patient Involvement Network
  Kidney Research UK
  National Kidney Federation
  Polycystic Kidney Disease Charity
  South Asian Health Foundation
  Specialised Healthcare Alliance
Professional groups Association of Renal Industries
  Association of Renal Technologists
  British Association of Urological Nurses
  British Geriatrics Society
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal Pharmaceutical Society
  Royal Society of Medicine
  Society for DGH Nephrologists
  UK Clinical Pharmacy Association
  UK Kidney Association
  UK Renal Pharmacy Group
Associated public health groups Public Health Wales
  UK Health Security Agency
Comparator companies Boehringer Ingelheim (empagliflozin)
General commentators All Wales Therapeutic and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health - Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare Products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Alliance
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Government
  Welsh Health Specialised Services Committee
Relevant research groups Centre for Kidney Research and Innovation
  Cochrane Kidney and Transplant Group
  Genomics England
  MRC Clinical Trials Unit
  National Institute for Health & Care Research


Key events during the development of the guidance:

Date Update
17 May 2024 Invitation to participate
17 May 2024 Invitation to participate
17 May 2024 In progress

For further information on how we select topics for development, please see our page about topic selection